| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A putative urinary biosignature for diagnosis and follow-up of tuberculous meningitis in children: outcome of a metabolomics study disclosing host–pathogen responses
|
Mason, Shayne
|
|
2016
|
12 |
7 |
p. 1-16
|
article
|
| 2 |
Erratum to: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
|
Hao, Desirée
|
|
2016
|
12 |
7 |
p. 1-2
|
article
|
| 3 |
LC–MS based global metabolite profiling: the necessity of high data quality
|
Engskog, Mikael K. R.
|
|
2016
|
12 |
7 |
p. 1-19
|
article
|
| 4 |
Metabolic analysis of the response of Pseudomonas putida DOT-T1E strains to toluene using Fourier transform infrared spectroscopy and gas chromatography mass spectrometry
|
Sayqal, Ali
|
|
2016
|
12 |
7 |
p. 1-12
|
article
|
| 5 |
Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
|
Stoessel, Daniel
|
|
2016
|
12 |
7 |
p. 1-14
|
article
|
| 6 |
Metabolomics meets functional assays: coupling LC–MS and microfluidic cell-based receptor-ligand analyses
|
Henquet, M. G. L.
|
|
2016
|
12 |
7 |
p. 1-13
|
article
|
| 7 |
NEWS: the 2016 Metabolomics publication awards
|
Goodacre, Royston
|
|
2016
|
12 |
7 |
p. 1-2
|
article
|
| 8 |
Normalization techniques for PARAFAC modeling of urine metabolomic data
|
Gardlo, Alžběta
|
|
2016
|
12 |
7 |
p. 1-13
|
article
|
| 9 |
Pharmacometabolomics in drug safety and drug-exposome interactions
|
Beger, Richard D.
|
|
2016
|
12 |
7 |
p. 1-11
|
article
|
| 10 |
Pharmacometabolomics informs pharmacogenomics
|
Neavin, Drew
|
|
2016
|
12 |
7 |
p. 1-6
|
article
|
| 11 |
Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM)
|
Lane, Andrew N.
|
|
2016
|
12 |
7 |
p. 1-15
|
article
|
| 12 |
Recon 2.2: from reconstruction to model of human metabolism
|
Swainston, Neil
|
|
2016
|
12 |
7 |
p. 1-7
|
article
|
| 13 |
Regular expressions of MS/MS spectra for partial annotation of metabolite features
|
Matsuda, Fumio
|
|
2016
|
12 |
7 |
p. 1-14
|
article
|
| 14 |
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS 1H NMR spectroscopy
|
Madhu, Basetti
|
|
2016
|
12 |
7 |
p. 1-11
|
article
|
| 15 |
Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS
|
Wang, Jialin
|
|
2016
|
12 |
7 |
p. 1-10
|
article
|
| 16 |
Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC–MS metabolomics
|
Cowan, Elaine
|
|
2016
|
12 |
7 |
p. 1-14
|
article
|
| 17 |
Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1
|
Carlisle, Samantha M.
|
|
2016
|
12 |
7 |
p. 1-12
|
article
|
| 18 |
Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation
|
van der Hooft, Justin J. J.
|
|
2016
|
12 |
7 |
p. 1-15
|
article
|
Journal description